The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells.

[1]  John Gaffney,et al.  Identification of differential protein expression associated with development of unstable human carotid plaques. , 2006, The American journal of pathology.

[2]  W. Seeger,et al.  Transforming Growth Factor-β-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3]  Chien Ho,et al.  Biliverdin Administration Prevents the Formation of Intimal Hyperplasia Induced by Vascular Injury , 2005, Circulation.

[4]  A. Bitto,et al.  Lipid peroxidation triggers both c-Jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK) activation and neointimal hyperplasia induced by cessation of blood flow in the mouse carotid artery. , 2005, Atherosclerosis.

[5]  Jui‐I Chao,et al.  Survivin and p53 Modulate Quercetin-induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[6]  Yu-Chih Liang,et al.  Concentration-dependent differential effects of quercetin on rat aortic smooth muscle cells. , 2004, European journal of pharmacology.

[7]  Teiji Wada,et al.  Mitogen-activated protein kinases in apoptosis regulation , 2004, Oncogene.

[8]  J. Tamargo,et al.  Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. , 2004, Molecular pharmacology.

[9]  J. Tamargo,et al.  Thromboxane A2-Induced Inhibition of Voltage-Gated K+ Channels and Pulmonary Vasoconstriction: Role of Protein Kinase C&zgr; , 2003, Circulation research.

[10]  H. Neil,et al.  The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies , 2003, European Journal of Clinical Nutrition.

[11]  Shokei Kim,et al.  Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. , 2003, Journal of pharmacological sciences.

[12]  Young-Choon Lee,et al.  Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. , 2003, Biochemical and biophysical research communications.

[13]  H. Lau.  Cytotoxicity of nitric oxide donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis. , 2003, Atherosclerosis.

[14]  T. Warner,et al.  Intimal Smooth Muscle Cells as a Target for Peroxisome Proliferator-Activated Receptor-&ggr; Ligand Therapy , 2002, Circulation research.

[15]  M. Yoshizumi,et al.  Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. , 2002, Biochemical and biophysical research communications.

[16]  K. Bland,et al.  Quercetin inhibits human vascular smooth muscle cell proliferation and migration. , 2002, Surgery.

[17]  M. Yoshizumi,et al.  Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. , 2001, Molecular pharmacology.

[18]  Ernesto L. Schiffrin,et al.  Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis , 2001, Hypertension.

[19]  Y. Kaneda,et al.  Gene Transfer of Dominant-Negative Mutants of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Prevents Neointimal Formation in Balloon-Injured Rat Artery , 2001, Circulation research.

[20]  Jen-kun Lin,et al.  Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator‐activated receptor‐γ by flavonoids in mouse macrophages , 2001, FEBS letters.

[21]  J. Tamargo,et al.  Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats , 2001, British journal of pharmacology.

[22]  H. Lau.  Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. , 1999, Cardiovascular research.

[23]  I. Tsukamoto,et al.  Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA level and the upregulation of p21WAF1CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy. , 1999, Biochimica et biophysica acta.

[24]  Shokei Kim,et al.  Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. , 1998, Circulation.

[25]  P L Weissberg,et al.  Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Fritsche,et al.  Flavonoids activate wild-type p53. , 1996, Oncogene.

[27]  M. Frid,et al.  Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. , 1994, Circulation research.

[28]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[29]  J. Tamargo,et al.  Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. , 1993, General pharmacology.

[30]  S. Schwartz,et al.  Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. , 1992, Circulation research.

[31]  R. Mason,et al.  The production of reactive oxygen species by dietary flavonols. , 1990, Free radical biology & medicine.

[32]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[33]  R. Lockshin,et al.  Cell death in biology and pathology , 1981 .

[34]  A. Wyllie.  Cell death: a new classification separating apoptosis from necrosis , 1981 .

[35]  Pei-shan Wu,et al.  Biochemical and Biophysical Research Communications , 1960, Nature.